BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 22443981)

  • 1. Approach to and treatment of differentiated thyroid carcinoma.
    Pacini F; Castagna MG
    Med Clin North Am; 2012 Mar; 96(2):369-83. PubMed ID: 22443981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis and long-term results of treatment of patients with differentiated thyroid carcinoma].
    Sedov VM; Khmelevskaia VA
    Vestn Khir Im I I Grek; 2011; 170(4):64-7. PubMed ID: 22191261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiated thyroid carcinoma, 1972-1992. Follow-up, detection of recurrences and prognostic factors].
    Obiols G; Simó R; Burgos R; Tresserras R; Galofré P; Masmiquel L; Hernández C; Mesa J
    Med Clin (Barc); 1997 Nov; 109(19):738-43. PubMed ID: 9470182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Outcomes of long-term combined treatment in follicular thyroid carcinoma].
    Baranauskas Z; Valuckas KP; Tiskevicius S
    Medicina (Kaunas); 2010; 46(4):268-74. PubMed ID: 20571295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of differentiated carcinoma of the thyroid gland].
    Mimura T; Ito K
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1184-9. PubMed ID: 9379097
    [No Abstract]   [Full Text] [Related]  

  • 6. Thyroid suppression and medical ablation for differentiated thyroid cancer.
    Dunn JT
    Arch Otolaryngol Head Neck Surg; 1986 Nov; 112(11):1207-9. PubMed ID: 3755995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
    Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
    Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of total thyroidectomy in the management of differentiated thyroid cancer.
    Stephenson BM; Wheeler MH; Clark OH
    Curr Opin Gen Surg; 1994; ():53-9. PubMed ID: 7584009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Limited radical approach in differentiated thyroid gland cancers. A prospective study of 107 patients].
    Engel U; Kucharski A; Zornig C
    Chirurg; 1994 Dec; 65(12):1095-8; discussion 1098-9. PubMed ID: 7851141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Differentiated thyroid cancers].
    Gorgone S; Campennì A; Calbo E; Catalfamo A; Sciglitano P; Sofia L; Niceta M; Borzì R; Calbo L
    G Chir; 2009; 30(1-2):26-9. PubMed ID: 19272228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of pediatric differentiated thyroid cancer: An overview for the pediatric oncologist.
    Prasad PK; Mahajan P; Hawkins DS; Mostoufi-Moab S; Venkatramani R
    Pediatr Blood Cancer; 2020 Jun; 67(6):e28141. PubMed ID: 32275118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
    Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
    Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial and Dynamic Risk Stratification of Pediatric Patients With Differentiated Thyroid Cancer.
    Sung TY; Jeon MJ; Lee YH; Lee YM; Kwon H; Yoon JH; Chung KW; Kim WG; Song DE; Hong SJ
    J Clin Endocrinol Metab; 2017 Mar; 102(3):793-800. PubMed ID: 27809646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated Thyroid Cancer-Treatment: State of the Art.
    Schmidbauer B; Menhart K; Hellwig D; Grosse J
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of refractory thyroid cancer.
    Berdelou A; Lamartina L; Klain M; Leboulleux S; Schlumberger M
    Endocr Relat Cancer; 2018 Apr; 25(4):R209-R223. PubMed ID: 29371330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
    Sacks W; Wong RM; Bresee C; Braunstein GD
    Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.